QSS
IMDZ

Quantitative Systematic Strategies’s Immune Design Corp. IMDZ Stock Holding History

Quantitative Systematic Strategies’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,716
Closed -$47K – 947
2018
Q3 		$47K Buy
+13,716
New +$51.5K 0.01% 600

Other funds holding IMDZ

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quantitative Systematic Strategies's IMDZ Position: Q4 2018 in Review

Quantitative Systematic Strategies sold out of Immune Design Corp. (IMDZ) in Q4 2018, closing a stake of 13,716 shares — an estimated $47K sold.

Quantitative Systematic Strategies first reported a position in IMDZ in Q3 2018 and held it in 1 quarter. The position peaked at $47K in Q3 2018. 64 funds tracked by Wall St. Rank hold IMDZ as of Q4 2018.

  • Quantitative Systematic Strategies reported no remaining Immune Design Corp. position as of Q4 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 13,716 Immune Design Corp. shares in Q4 2018, an estimated $47K.
  • Quantitative Systematic Strategies first reported a position in Immune Design Corp. in Q3 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Immune Design Corp. position peaked at $47K in Q3 2018.
  • 64 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2018, filed 12 Feb 2019.